| Alice Kathleen Lingen, MD | |
|
425 7th St Nw, Cass Lake, MN 56633-3360 | |
| (218) 335-3200 | |
| (218) 335-3284 |
| Full Name | Alice Kathleen Lingen |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 425 7th St Nw, Cass Lake, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639186752 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 166087-1205 (Utah) | Primary |
| Entity Name | Department Of Health & Human Services Phs Ihs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194754382 PECOS PAC ID: 7517879794 Enrollment ID: O20031105000353 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
The heartbeat is the result of rhythmic contractions of the heart muscle, which are in turn regulated by electrical signals called action potentials. Action potentials result from the controlled flow of ions into heart muscle cells (depolarization) through channels in their membranes, and are followed by a compensating reverse ion current (repolarization), which restores the original state. If the duration of the repolarization phase is not just right, the risk of ventricular arrhythmia and sudden cardiac death increases significantly.
The recent results of the National Survey of Children's Health showed roughly 1 in 90 US children are affected by Autism Spectrum Disorder (ASD). Add to this the gamut of other disorders (Attention Deficit Disorder (ADD/ADHD), Anxiety disorders, Sensory Processing Disorder (SPD), etc.) our children can be faced with, and it isn't surprising that an increasing number of special needs children are in our classrooms.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alice Kathleen Lingen, MD 425 7th St Nw, Cass Lake, MN 56633-3360 Ph: (218) 335-3200 | Alice Kathleen Lingen, MD 425 7th St Nw, Cass Lake, MN 56633-3360 Ph: (218) 335-3200 |
News Archive
It is now shockingly clear that poor health is a much broader and deeper problem than past studies have suggested. An authoritative report issued by the Institute of Medicine this week found that, on average, Americans experience higher rates of disease and injury and die sooner than people in other high-income countries.
The heartbeat is the result of rhythmic contractions of the heart muscle, which are in turn regulated by electrical signals called action potentials. Action potentials result from the controlled flow of ions into heart muscle cells (depolarization) through channels in their membranes, and are followed by a compensating reverse ion current (repolarization), which restores the original state. If the duration of the repolarization phase is not just right, the risk of ventricular arrhythmia and sudden cardiac death increases significantly.
The recent results of the National Survey of Children's Health showed roughly 1 in 90 US children are affected by Autism Spectrum Disorder (ASD). Add to this the gamut of other disorders (Attention Deficit Disorder (ADD/ADHD), Anxiety disorders, Sensory Processing Disorder (SPD), etc.) our children can be faced with, and it isn't surprising that an increasing number of special needs children are in our classrooms.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 5 days ago
Matei Teodorescu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 425 7th St Nw, Cass Lake, MN 56633 Phone: 218-335-3200 |